Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Amydis is a pharmaceutical company that focuses on developing innovative chemistry to detect diseases.
PETcoil makes multimodality molecular imaging more accurate, sensitive, and affordable.
Lightengale develops medical devices for improved ICU infusion lines.
Behaivior is a digital health company democratizing mental health recovery and wellness using AI, behavioral health tech, and wearables.
Mustang Bio is a clinical-stage biopharmaceutical company .
Versiti provide innovative, value added solutions in the fields of transfusion medicine, transplantation, and blood-related diseases.
Sonomotion is a medical device manufacturing company that specializes in providing medical solutions for kidney stones disease.
Autonomous Medical Devices is a developer of a medical device designed to detect pathogens and viruses.
Joyuus is a women's health startup dedicated on creating easily accessible well-being for mothers.
Stem Pharm's synthetic biomaterials support the optimization of cell expansion.
Arc Bio provides research and development in the physical, engineering, and life sciences.
Perspective Therapeutics focuses on advancing cancer treatments employing radiation, radiopharmaceuticals, and imaging technology.
Behavioral Biomarker Infrastructure for aging adults — catching functional decline before it becomes a crisis.
Phase provides 3D-printing medical devices for microfluidics.
HealthRhythms develops a mental health assessment and treatment platform to measure and monitor health conditions.
A continuous, passive, home-health remote monitoring platform.
Arcascope makes apps that utilize algorithms that track circadian rhythms and generates personalized recommendations.
NeuroGeneces measures and improves Brain Health
Immuto Scientific is a biotechnology services company that provides analytical insights to pharmaceutical companies for drug discovery.
Bright Uro is an early-stage medical technology company.
Syntis Bio operates as a late-stage preclinical company that develops oral therapies for obesity, diabetes, and rare diseases.
South Rampart Pharma is a clinical-stage life science company focusing on overcoming current pain medicines risks.
Therini Bio specializes in fibrin-targeting therapies to treat inflammatory neurological and retinal diseases.
Actuated Medical is engaged in outsourced research and development, designing, modeling, prototyping, and manufacturing medical devices.
National Institutes of Health has invested in 491 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institutes of Health's top investment sectors include Health Care, Biotechnology, Pharmaceutical, Medical Device, Health Diagnostics. The firm invests across 32 different industry categories.
Among tracked funding rounds, Perspective Therapeutics received $175.0M in a Post-IPO Equity round. National Institutes of Health's total known invested capital is $2.4B.
National Institutes of Health's average investment size is $6.2M across its portfolio of 491 companies.
Recent National Institutes of Health portfolio additions include Amydis, PETcoil, Lightengale, Behaivior, Mustang Bio. These companies were founded in 2020 or later.